Douglas P. Zipes

Cardiology and Cardiovascular Medicine · 2001–2018

A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Douglas P. Zipes trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Donald M. Bers

Who trusts Douglas P. Zipes overall

  1. Roohallah Alizadehsani
  2. Jafar Habibi

Papers from Douglas P. Zipes's perspective

Ordered by how strongly the researchers Douglas P. Zipes trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Natural History of Brugada Syndrome: Insights for Risk Stratification and Management (Circulation)
  2. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. (Journal of the American Medical Association (JAMA))
  3. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. (New England Journal of Medicine)
  4. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. (Circulation)
  5. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. (New England Journal of Medicine)
  6. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation… (The Lancet)
  7. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg… (European Heart Journal)
  8. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  9. The effect of cardiac resynchronization on morbidity and mortality in heart failure. (New England Journal of Medicine)
  10. Risk stratification in the long-QT syndrome. (New England Journal of Medicine)

Their papers